Equities

Rohto Pharmaceutical Co Ltd

Rohto Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)3,514.00
  • Today's Change-45.00 / -1.26%
  • Shares traded131.50k
  • 1 Year change-13.45%
  • Beta0.3650
Data delayed at least 20 minutes, as of Sep 18 2024 03:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue270,840238,664199,646
OPERATING EXPENSES
Cost of revenue total113,554101,24383,476
Selling, general and admin. expenses, total101,42490,05776,301
Depreciation/amortization2,4232,3392,113
Unusual expense(income)9161,294952
Other operating expenses, total1.001.001.00
Total operating expense231,708205,999171,583
Operating income39,13232,66528,063
Other, net622(484)(911)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes41,51834,29027,874
Provision for income taxes10,1237,8606,686
Net income after taxes31,39526,43021,188
Minority interest(457)(52)(60)
Net income before extra. Items30,93826,37821,128
Total extraordinary items------
Net income30,93826,37821,128
Inc.avail. to common excl. extra. Items30,93626,37721,127
Inc.avail. to common incl. extra. Items30,93626,37721,127
EPS RECONCILIATION
Basic/primary weighted average shares228228228
Basic/primary eps excl. extra items13611693
Basic/primary eps incl. extra items13611693
Dilution adjustment------
Diluted weighted average shares229229229
Diluted eps excl. extra items13511592
Diluted eps incl. extra items13511592
COMMON STOCK DIVIDENDS
DPS - common stock primary issue272218
Gross dividend - common stock6,1595,0184,106
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental196247248
SUPPLEMENTAL INCOME
Depreciation, supplemental8,2517,4187,216
Total special items1,3521,6771,409
NORMALISED INCOME
Normalized income before taxes42,87035,96729,283
Effect of special items on income taxes223297228
Income tax excluding impact of special items10,3468,1576,914
Normalized income after tax32,52427,81022,369
Normalized income avail. to common32,06527,75722,308
Basic normalized EPS14112298
Diluted normalized EPS14012197
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.